Building the future of MedTech innovation
We are excited to announce our partnership with Zühlke Group, bringing together complementary expertise to transform how MedTech approaches risk analysis.
By combining Zühlke's extensive experience in MedTech innovation and product development with Reshape's AI-powered risk modelling technology, we aim to help R&D teams shift risk analysis from a retrospective compliance exercise to a continuous, system-level capability that supports better decisions throughout the product development lifecycle.
This collaboration is built on a shared vision for the responsible adoption of AI in regulated industries.
We believe AI should not only be powerful, but also explainable, rigorous, and seamlessly integrated into engineering workflows. By making risk identification more transparent, supporting compliance with standards such as ISO 14971, and enabling teams to identify and address critical issues earlier, we can help engineers make more informed decisions while reducing costly rework.
Together, we look forward to empowering MedTech teams with trustworthy AI solutions that strengthen human expertise and contribute to the development of safer medical technologies.